Clinical Trial Update: A Research Study to Find Out How Semaglutide Works in the Kidneys Compared to Placebo, in People With Type 2 Diabetes and Chronic Kidney Disease (the REMODEL Trial) [Phase 3]

View source ↗

Summary

The document announces the completion of REMODEL, a Phase 3 trial comparing semaglutide with placebo in adults with type 2 diabetes and chronic kidney disease, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 2, Chronic Kidney Disease | Phase 3 | Status: COMPLETED | Results posted: 2026-01-14